Kewaunee Scientific CorpKEQU
Price$33.91Intrinsic value$32.365% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $277.2M+15.3% YoYTTM through 31 Jul 2026
Net Income $8.2M-27.8% YoYTTM through 31 Jul 2026
Free Cash Flow $10.9MTTM through 31 Jul 2026

Margins

Current
Gross Margin28.1%
EBITDA Margin7.7%
Operating Margin4.0%
Net Margin3.0%

Returns

15.3%ROE
6.3%ROA
9.6%ROIC

Balance Sheet Health

Debt / Equity0.68x
Current Ratio2.10x
Net Debt$41.5M
Cash & Equivalents$8.2M

Quality Metrics

Altman Z-Score3.41
Piotroski F-Score7 / 9
FCF Margin3.9%
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $282M
Diluted EPS$2.76TTM
'20'21'22'23'24'25'26
FY2026: $3.22

Dividend

$0.57Per share, FY20190.00%Yield

Capital Allocation

R&D Spend$898K
Capex Intensity1.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.